Inside the tumor: how do #DendriticCells shape cancer immunity? Meet our #DC2026 Plenary 6 speakers Miriam Merad, Santiago Zelenay & Max Krummel! ⏰ Last chance! Late-Breaking Abstracts close TOMORROW, August 28! 🙏🔁

1/2 The Immunity by Design: In Vivo Immune Cell Engineering Conference introduces Session 1: Cell Engineering & Reprogramming. The Pereira lab will share the stage with Judit Svensson Arvelund and Özcan Met to discuss emerging approaches in immune cell engineering and cancer immunotherapy.

1/2 The Immunity by Design: In Vivo Immune Cell Engineering Conference introduces Session 2: Synthetic Biology & Gene Editing, joining William Nyberg (Karolinska Institutet), Axel Hyrenius-Wittsten (Lund University), and Mirco Friedrich (DKFZ German Cancer Research Center).

Next week, Dr. Brian Brown from the Icahn School of Medicine at Mount Sinai will be joining us to discuss his lab's work on identifying factors that control immunity and translating these findings into strategies against #cancer or viruses. 🔬 Check out their latest work: https://bit.ly/4fd915L

#Agenda The Immunity by Design In Vivo Immune Cell Engineering Conference 22-23 October 2026 Palestra et Odeum, Lund @juditarvelund.bsky.social, Özcan Met. Tina C. Ivkovic, Mikael Mattsson, Anahita Bakochi @cellreprolab.bsky.social / @lund-university.bsky.social Info: immunitybydesign.se

Very cool paper in @cp-immunity.bsky.social showing that a "dietary modulation of NKT-XCL1-cDC1 axis in combination with immune check points inhibitors may open avenues for improved treatments of colon cancer".👇 www.sciencedirect.com/science/arti...

Dietary sulfur amino acids enhance anti-tumor immunity in colon cancer via an NKT cell-XCL1-cDC1 circuit

The efficacy of immune checkpoint inhibitors (ICIs) in colon cancer (CC) is limited by the tolerogenic immune landscape of both the tumor and the inte…

sciencedirect.com

New piece on the decision of #ERC to reverse their stricter rules after the community came together to voice our opinions - a great example of the power of collective action! Very happy to have been part of this - and to see how we can now build on this momentum 🙌 www.nature.com/articles/d41... 🧪

Prestigious European science funder scraps stricter rules after researcher backlash

The tough new policy was introduced to curb submissions, but drew criticism from researchers.

nature.com

Reminder for the 51st Annual Meeting of the Scandinavian Society for Immunology! The meeting will take place September 7-10, 2026 in Bergen and includes a summer school program Early bird registration & abstract submission deadline: June 1st For full program and to register: www.ssi2026.no

Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models - @mitkochinstitute.bsky.social go.nature.com/42td2fh

Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models - Nature Biotechnology

Immune-remodeling mRNAs delivered in lipid nanoparticles boost antitumor immunity.

go.nature.com

Excited to share recent work from our lab in @bloodjournal.bsky.social #BloodAdvances! We studied the impact of CD45-targeted radioimmunotherapy (RIT) on the bone marrow vascular niche. Turns out the vasculature is majorly disrupted by hematopoietic targeted RIT ☢️🩸 shorturl.at/qzWIB

📢 Tune in to this week's episode! Dr. Alfred Singer at the National Cancer Institute Center for Cancer Research discusses his pioneering work on thymus development and T cell differentiation, including how T cells are selected to become CD4 helper or CD8 cytotoxic cells. 🎧 https://bit.ly/4f2ci85

Marco et al. sought to expand the utility of immunizing radiation (IR) therapy by intratumorally delivering agents to remodel the tumor immune microenvironment (TIME). bit.ly/4t8ud0W

Chronic inflammation has long been linked to cancer, but how is that history retained in the tissue? In a new #Nature study, Nagaraja et al show that colitis leaves a lasting epigenetic memory in colonic stem cells, which persists after inflammation resolves & primes for subsequent tumor growth 🧪🔬

Remembrance of inflammations past

Chronic inflammation increases the risk of colon cancer. This inflammation drives epigenetic changes in the nucleus of stem cells that promote tumour formation.

nature.com

Thanks @the-node.bsky.social @biologists.bsky.social for allowing spreading the word @kawresearch.bsky.social @scilifelab.se @remeseiro-lab.bsky.social thenode.biologists.com/join-the-sum...

Join the Summer School in TranscriptOMICS in Develoment and Disease — Sweden, June 23-26, 2026 - the Node

The School will be a 4-day (23-26 June 2026) Theory&Computation course in a splendid Swedish inland Resort (2 hours away from Stockholm - our bus will

thenode.biologists.com

While TOX in CD8+ T cells is associated with exhaustion and poor prognosis, recent work by Naizir et al. showed the opposite effect in CD4+ T cells, where TOX expression was associated with TH1 differentiation, effector function, antitumor immunity, and autoimmune pathology. bit.ly/4rI2Vgt

We are seeking a highly motivated scientist with expertise in mouse embryo manipulation and the generation of genetically engineered mouse models. This is a permanent position with competitive compensation. Contact me via direct message if interested. Please share!

Looking for an awesome new PhD student, working at the intersection of #Virology and #Cancer research, looking to develop new therapies for #Glioma #Glioblastoma. Stipend, consumables and fees (UK/EU rates only) covered. #BeAVirusTinkerer #VITAL #TeamWAVU www.findaphd.com/phds/project...

Evolution and adaptation of improved adenoviral platforms for the treatment of glioblastoma at Cardiff University on FindAPhD.com

PhD Project - Evolution and adaptation of improved adenoviral platforms for the treatment of glioblastoma at Cardiff University, listed on FindAPhD.com

findaphd.com

I am really excited to share that our review on preclinical models of breast cancer metastasis is out in npj Breast Cancer! We provide a comprehensive overview of the major preclinical models used to study breast cancer metastasis www.nature.com/articles/s41...

Excited to share the final first-author paper of my PhD is online in Cancer Discovery @aacrjournals.bsky.social! doi.org/10.1158/2159... We identify an SPP1⁺ macrophage–IL-6–CRP inflammatory axis linked to resistance to checkpoint blockade in bladder cancer @bhardwajlab.bsky.social

This International Women's Day, we asked these award winners to name a woman who has had a positive impact on their career and wellbeing go.nature.com/4uawrOB

‘No one quite like her’: meet the female colleagues who inspire these award-winning women in science

To mark International Women’s Day, Nature asked winners of its awards programmes to nominate a colleague who brings out the best in them.

go.nature.com

More leading voices for #DayofImmunology 2026🧬 Makoto Miyara (Sorbonne University / Pitié-Salpêtrière) will join our #DOI2026 webinar, bringing clinical insight on #RegulatoryTcells in transplantation and autoimmunity. 📅 April 29 at 15:00 Registration 🔗👇 @yefis-immunology.bsky.social

International Union of Immunological Societies@iuis-online.bsky.social · 7mo ago

💪 More leading voices join the stage. Prof. Makoto Miyara will speak at #DayofImmunology 2026. From transplantation to autoimmune disease, his work connects immune regulation to patient care. Regulatory T cells in therapeutic strategy. 📅 April 29 🔗 https://loom.ly/q1XCaxA #DOI2026

The 3 hardest things to learn as a scientist: 1. Trust the data.. especially when it’s not what you expected, 2. Trust the data.. allowing it to change your direction, 3. Trust the data.. but not too much: test with new data at every turn.

Itai Yanai@itaiyanai.bsky.social · last yr.

90% of doing science is being open to new ideas.

Excited to share our review "Pipe dream to Pipeline: Journey of cancer vaccines and the road ahead" that is now published in Cell Reports Medicine by Cell Press! (1/4)

Pipe dream to pipeline: Journey of cancer vaccines and the road ahead

Onkar et al. discuss the current landscape of therapeutic cancer vaccines in the context of recent clinical trials, with a special focus on neoantigen vaccines. They also highlight challenges and scop...

cell.com

Registration is now open and an all-in roster of immunologists anchor the premiere Dendritic cell meeting. www.dc2026sandiego.com/invited-spea... Sunny (blue state) San Diego. Sessions devoted to honoring 15 year anniversary of Nobel prize (Steinman) and translational advances…what is not to like.?

Too much data, too little thinking. A important essay from Ruslan Medzhitov on the importance of understanding data, not just generating it. A must read. @Yale www.nature.com/articles/s41...

On the balance of knowledge - Nature Reviews Immunology

Ruslan Medzhitov shares his thoughts on the balance between generating data and developing theories in immunology, with a focus on exploring the rules that govern complex systems.

nature.com

Registration for the PALS Summer School in Transcriptomics is Open 🧬 23-26 June 2026 www.trippus.net/summerschool... Join us in this wonderful place 🇸🇪 to learn Theory & Computation from Famous Scientists in the Field w @remeseiro-lab.bsky.social Support by @scilifelab.se & @kawresearch.bsky.social

Claudio Cantù@claudiocantu81.bsky.social · 9mo ago

Save the date 23-26 June 2026 The Third Edition of The PALS Summer School in OMICS is on! Soon registration+other info If you are interested to teach (if you are a former participant) please get in touch with me or @remeseiro-lab.bsky.social 🙏 @scilifelab.se @kawresearch.bsky.social

Registration is OPEN for the cancer research community to join us for the #EACR2026 Congress! 🥳 Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 21 April. 2026.eacr.org

Understanding why cancers relapse - sometimes years or decades after successful treatment - is a major challenge in the cancer field This perspective in Nature discusses several of the important recent advances and new studies in the field of tumor dormancy 🧪⚕️ www.nature.com/articles/d41...

Why cancer can come back years later — and how to stop it

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

nature.com

Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity: Immunity www.cell.com/immunity/ful...

Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity

CCR7+ dendritic cells (DCs) are pivotal for antitumor immunity. Zitti, Duval et al. find that intratumoral CCR7+ DCs form perivascular hubs dependent on CCL19-CCR7 signaling. Regulatory T cells (Tregs...

cell.com